Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,082 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prognostic Impact of Serum SCC Antigen in the 566 Upfront Surgery Group of Esophageal Squamous Cell Carcinoma: A Multi-Institutional Study of the Japan Esophageal Society.
Suzuki T, Yajima S, Okamura A, Yoshida N, Taniyama Y, Murakami K, Ohkura Y, Nakajima Y, Yagi K, Fukuda T, Ogawa R, Hoshino I, Kunisaki C, Narumiya K, Tsubosa Y, Yamada K, Shimada H. Suzuki T, et al. Among authors: yagi k. Ann Thorac Cardiovasc Surg. 2024;30(1):24-00028. doi: 10.5761/atcs.oa.24-00028. Ann Thorac Cardiovasc Surg. 2024. PMID: 38583987 Free PMC article.
Low pretherapy skeletal muscle mass index is associated with an increased risk of febrile neutropenia in patients with esophageal cancer receiving docetaxel + cisplatin + 5-fluorouracil (DCF) therapy.
Nara K, Yamamoto T, Sato Y, Yagi K, Kawasaki K, Toriumi T, Takada T, Seto Y, Suzuki H. Nara K, et al. Among authors: yagi k. Support Care Cancer. 2023 Feb 4;31(2):150. doi: 10.1007/s00520-023-07609-6. Support Care Cancer. 2023. PMID: 36737558 Free PMC article.
Response to chemotherapy could predict the prognosis of esophageal squamous cell carcinoma treated with neoadjuvant docetaxel, cisplatin, and fluorouracil (DCF) followed by surgery: long-term results in a single institute.
Sato Y, Mori K, Atsumi S, Sakamoto K, Oya S, Okamoto A, Urabe M, Miwa Y, Yajima S, Yagi K, Nomura S, Yamashita H, Seto Y. Sato Y, et al. Among authors: yagi k. Esophagus. 2024 Oct;21(4):514-522. doi: 10.1007/s10388-024-01062-y. Epub 2024 Jul 10. Esophagus. 2024. PMID: 38987434 Free PMC article.
Prior treatment with oxaliplatin-containing regimens and higher total bilirubin levels are risk factors for neutropenia and febrile neutropenia in patients with gastric or esophagogastric junction cancer receiving weekly paclitaxel and ramucirumab therapy: a single center retrospective study.
Nara K, Yamamoto T, Yamashita H, Yagi K, Takada T, Seto Y, Suzuki H. Nara K, et al. Among authors: yagi k. BMC Cancer. 2023 Oct 13;23(1):979. doi: 10.1186/s12885-023-11469-y. BMC Cancer. 2023. PMID: 37833660 Free PMC article.
2,082 results